Search filters

List of works by Adnan M Nagrial

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

scientific article published on 18 March 2020

An Online Learning Module to Increase Self-Efficacy and Involvement in Care for Patients With Advanced Lung Cancer: Research Protocol

scientific article published on 08 August 2016

Bone disease in prostate cancer.

scientific article published in March 2010

Chimeric Antigen Receptors for the Tumour Microenvironment

scientific article published on 01 January 2020

Clinical and pathologic features of familial pancreatic cancer

scientific article published on 14 October 2014

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies

scientific article published on 02 May 2020

Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial

scientific article published on 30 July 2020

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

scholarly article

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma

scientific article published on 16 May 2014

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater

scientific article published on 25 February 2013

Hypermutation In Pancreatic Cancer

scientific article

Immunotherapy of Ipilimumab and Nivolumab in patients with advanced neuroendocrine tumours: a subgroup analysis of the CA209-538 clinical trial for rare cancers

scientific article published on 12 June 2020

Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia

scientific article published on 8 December 2016

Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future

scientific article published on 01 June 2018

Non-coding RNA and immune-checkpoint inhibitors: friends or foes?

scientific article published on 07 May 2020

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

scientific article

Personalising pancreas cancer treatment: When tissue is the issue

scientific article

Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors

scientific article published on 17 March 2020

Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial

scientific article published on May 2015

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer

scientific article published on 30 November 2018

Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancer

scientific article published on 01 June 2019

Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer

scholarly article

Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling

scientific article published on 3 June 2016

Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities

scientific article

Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials

scientific article

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma

article published in 2018

The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies

scientific article published on 21 December 2019